publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
communityacquir
respiratori
infect
children
pharyng
donald
middleton
md
pharyng
encompass
infect
irrit
pharynx
tonsil
rare
found
infant
younger
year
uncommon
infant
younger
year
ill
peak
age
year
recur
throughout
life
especi
whenev
peopl
congreg
winter
month
viral
agent
usual
u
l
p
r
although
group
phemolyt
streptococcu
gabh
caus
pharyng
usual
bacteri
caus
may
caus
signific
nonsuppur
sequela
form
acut
rheumat
fever
arf
acut
glomerulonephr
agn
type
pharyng
lead
suppur
complic
includ
cervic
lymphaden
peritonsillar
abscess
retropharyng
abscess
sinus
otiti
media
usual
unusu
caus
pharyng
list
virus
common
agent
respons
case
rhinoviru
b
adenoviru
epsteinbarr
viru
ebv
b
herp
simplex
c
influenza
parainfluenza
e
coronaviru
enteroviru
polioviru
coxsackieviru
echoviru
less
common
agent
respons
case
uncommon
agent
respons
less
case
st
infect
viru
bacteria
account
vast
major
case
parasit
fungu
rare
fault
caus
includ
trauma
irrit
cancer
variou
syndrom
unknown
caus
age
time
year
environ
exposur
dictat
like
caus
young
children
viral
agent
predomin
older
children
adolesc
gabh
bacteria
often
encount
adult
less
invas
bacteria
virus
found
equal
frequenc
studi
adult
acut
pharyng
gabh
found
group
c
streptococci
group
g
group
f
question
signific
mycoplasma
pneumonia
chlamydia
pneumonia
virus
thirtythre
patient
isol
organ
simultan
infect
two
organ
case
acut
pharyng
result
viral
n
f
et
n
hundr
virus
fail
induc
prolong
immun
infect
throat
one
hundr
type
one
subtyp
rhinoviru
caus
pharyng
coronaviru
least
three
type
adenoviru
type
parainfluenza
viru
type
incit
case
common
viral
caus
includ
influenza
viru
b
herp
simplex
viru
coxsackieviru
type
b
mani
agent
ebv
cmv
produc
pharyng
difficult
distinguish
clinic
group
streptococc
infectin
recent
note
produc
acut
sore
throat
similar
infecti
mononucleosi
im
except
infecti
mononucleosi
viral
pharyng
tend
develop
rhiniti
children
often
accompani
cough
rhiniti
cough
rare
gabh
pharyng
viral
diseas
pharyng
may
press
complaint
worsen
nasal
blockad
breath
via
mouth
especi
sleep
peopl
rhinoviru
coronaviru
cold
scratchi
sore
throat
similarli
influenza
parainfluenza
adenoviru
pharyng
discomfort
adult
viral
pharyng
fever
cough
tend
absent
edema
red
pharynx
usual
degre
exud
less
effus
bacteri
diseas
pain
lymphadenopathi
unusu
cours
event
gradual
center
nasal
discharg
initi
clear
day
greenish
anoth
day
clear
anoth
day
gone
although
viral
diseas
clinic
differenti
definit
bacteri
diseas
specif
viral
present
allow
diagnost
accuraci
primari
agent
im
ebv
usual
spread
saliva
rare
blood
transfus
selflimit
ill
incub
week
produc
sever
pharyng
common
complaint
malais
anorexia
chill
headach
usual
occur
develop
sore
throat
fever
region
lymphadenopathi
fatigu
gener
lymphadenopathi
hepatosplenomegali
complic
follow
day
fever
high
f
periorbit
edema
palat
petechia
tonsillar
exud
anginos
varieti
common
fig
patient
fine
variableform
rash
given
ampicillin
develop
diffus
itchi
maculopapular
erupt
durat
unwant
partial
diagnost
clue
nausea
vomit
afflict
infect
individu
diarrhea
renal
failur
uveiti
also
occur
less
physic
examin
often
show
extrem
tonsillar
hypertrophi
coat
membran
exud
pharyng
sever
day
may
interfer
swallow
next
day
resolv
fever
last
week
longer
week
lymphadenopathi
splenomegali
gener
resolv
wherea
malais
may
persist
month
ebv
resid
nasopharyng
cell
constant
nasopharyng
viral
shed
commonli
last
month
intermitt
shed
lifelong
patient
without
high
fever
sever
sore
throat
like
suffer
prolong
fatigu
person
return
school
work
week
rare
diagnosi
im
rest
clinic
suspicion
coupl
posit
antibodi
test
ebv
complet
blood
count
show
atyp
lymphocytosi
hematolog
complic
list
previous
monospot
test
reveal
heterophil
antibodi
patient
im
antibodi
direct
ebv
induc
ebv
ebvspecif
viral
capsid
antigen
igm
antibodi
best
indic
primari
infect
develop
case
viral
capsid
antigen
igg
marker
prior
infect
epsteinbarr
nuclear
antigen
antibodi
develop
within
week
use
marker
acut
infect
initi
neg
test
becom
posit
earli
antigendiffus
antibodi
suggest
sever
diseas
posit
earli
antigendiffus
iga
correl
higher
risk
nasopharyng
carcinoma
wherea
posit
earli
antigenrestrict
iga
suggest
risk
burkitt
lymphoma
earli
childhood
ebv
infect
often
asymptomat
adolesc
young
adult
particularli
like
develop
sever
pharyng
older
individu
therefor
like
ebv
fault
carriag
concomit
gabh
report
case
whether
individu
truli
infect
unclear
doubt
wisest
choic
cultur
throat
rapid
streptococc
antigen
test
treat
either
posit
treatment
ebv
larg
symptomat
littl
evid
support
old
advic
bed
rest
help
acetaminophen
ibuprofen
eas
pain
fever
steroid
dramat
reliev
airway
obstruct
sore
throat
fever
seem
improv
thrombocytopenia
hemolyt
anemia
may
help
lifethreaten
complic
use
neurolog
diseas
prednison
h
day
often
taper
ad
one
use
regimen
despit
worri
contrari
rebound
pharyng
follow
steroid
therapi
rare
present
usual
respond
second
howev
longterm
consequ
prescrib
steroid
patient
infect
viru
surviv
tissu
year
unknown
ebv
especi
worrisom
link
cancer
therefor
clinician
probabl
avoid
routin
prescrib
steroid
specif
antivir
therapi
acyclovir
ganciclovir
interferona
clinic
benefit
although
drug
reduc
viral
shed
patient
typic
im
monospot
ebv
titer
neg
may
cmv
pharyng
patient
infect
cmv
often
older
sexual
activ
higher
fever
greater
malais
less
promin
pharyng
lymphadenpathi
fact
pharynx
may
look
rel
normal
patient
ill
week
diagnosi
rest
isol
cmv
blood
deep
tissu
urin
saliva
coupl
fourfold
greater
antibodi
titer
rise
best
diagnost
test
cmvspecif
igm
igg
antibodi
titer
posit
igm
suggest
recent
infect
treatment
symptomat
unless
patient
immunocompromis
case
ganciclovir
foscarnet
may
provid
effect
adenoviru
may
produc
typic
pharyng
pharyngoconjunctiv
fever
occur
one
half
case
clue
latter
diagnosi
conjunct
commonli
follicular
one
fourth
patient
bilater
sore
throat
intens
common
upper
respiratori
tract
infect
extrem
pharyng
erythema
exud
often
evid
militari
personnel
tend
sicker
hoars
chest
pain
respiratori
distress
ill
resolv
spontan
day
children
uncompl
pharyng
commonli
caus
adenoviru
type
coxsackieviru
peak
occurr
late
summer
earli
fall
multipl
small
vesicl
lmm
size
tonsil
tonsillar
pillar
uvula
soft
palat
suggest
herpangina
caus
coxsackieviru
vesicl
may
enlarg
mm
red
ring
mm
size
may
number
remaind
pharynx
usual
normal
lesion
whitish
nodular
ill
refer
lymphonodular
pharyng
incub
period
present
complaint
usual
sudden
onset
fever
f
often
coryza
young
children
sever
odynophagia
fever
height
easili
may
develop
dehydr
one
quarter
also
vomit
older
children
develop
neck
pain
headach
back
pain
case
fortun
remain
rel
mild
day
ill
subsid
coxsacki
major
caus
hand
foot
mouth
diseas
incub
period
patient
develop
ulcer
tongu
buccal
mucosa
occasion
tonsillar
pillar
vesicl
develop
hand
feet
occasion
buttock
afflict
person
rare
sever
ill
week
ill
abat
mild
herp
simplex
viru
pharyng
indistinguish
viral
present
sever
diseas
usual
resembl
acut
gabh
pain
shallow
ulcer
red
border
vesicl
soft
palat
gum
lip
buccal
surfac
help
distinguish
herp
simplex
caus
fever
lymphadenopathi
frequent
children
younger
age
year
herp
gingivostomat
produc
sever
ulcer
lesion
buccal
mucosa
tongu
soft
palat
high
fever
f
intens
pain
recurr
form
cold
sore
common
individu
immunodefici
larg
pain
persist
oral
ulcer
suggest
herp
simplex
acyclovir
mgkg
everi
hour
intraven
mg
five
time
day
oral
day
famciclovir
valacyclovir
mg
three
time
day
oral
day
may
prove
help
sever
afflict
individu
characterist
caus
febril
pharyng
approxim
week
incub
follow
sore
throat
fever
myalgia
arthralgia
lethargi
lymphadenopathi
rash
follow
exud
tonsil
rare
ever
occur
sign
hiv
present
ulcer
aphthou
ulcer
pharyng
hyperemia
common
detail
histori
reveal
risk
influenza
b
pharyng
major
complaint
myalgia
headach
cough
also
promin
sever
pharyng
particularli
common
influenza
time
year
epidem
winter
earli
spring
coincid
peak
occurr
gabh
extrem
elev
temperatur
common
pharyng
tonsillar
exud
tender
cervic
node
uniformli
absent
pharyng
usual
resolv
day
treatment
drug
amantadin
mgkgd
divid
two
dose
maximum
mg
age
year
mg
twice
daili
age
year
older
day
rimantadin
may
hasten
resolut
surveil
system
public
health
depart
provid
real
tipoff
presenc
influenza
neighborhood
patient
special
risk
older
age
year
wish
protect
receiv
time
late
octob
earli
novemb
influenza
vaccin
bacteria
caus
pharyng
list
previous
common
import
gabh
pharyng
infect
organ
associ
arf
lesser
extent
agn
diagnosi
treatment
pharyng
must
part
common
base
knowledg
primari
care
physician
unlik
otiti
media
damag
endorgan
function
ie
hear
sinus
persist
prolong
irrit
time
bacteri
pharyng
selflimit
uncommonli
produc
sequela
complic
retropharyng
abscess
peritonsillar
abscess
suppur
cervic
lymphaden
occur
howev
readili
treat
surgic
nonsuppur
endorgan
damag
heart
arf
kidney
agn
manag
easili
import
bacteria
previous
list
review
follow
section
notic
absent
haemophilu
infuenza
moraxella
catarrkali
staphylococcu
aureu
epidermidi
streptococcu
pneumonia
bacteria
caus
mani
local
upper
airway
infect
pharyng
gabh
import
agent
acut
pharyng
abil
produc
local
suppur
diseas
peritonsillar
abscess
overwhelm
system
ill
toxic
shock
nonsuppur
sequela
arf
agn
organ
produc
mani
extracellular
toxin
three
type
pyrogen
exotoxin
b
c
caus
scarlet
fever
rash
streptolysin
toxic
erythrocyt
leukocyt
inhibit
oxygen
streptolysin
toxic
numer
cell
thermolabil
four
type
dnase
hyaluronidas
streptokinas
boon
cardiac
thrombosi
therapi
nadas
proteinas
amylas
esteras
toxin
allow
great
tissu
penetr
gabh
replic
everi
minut
spread
rapidli
almost
everi
bodi
tissu
subject
infect
skin
throat
favorit
target
hostdepend
surfac
receptor
site
streptococc
protein
key
common
organ
link
protein
highli
variabl
differ
known
structur
make
singl
antibodi
protect
virtual
imposs
project
streptococcu
organ
appear
fuzzi
ball
higherpow
microscopi
nterminu
neg
charg
repel
neutrophil
also
bind
factor
h
human
serum
regulatori
protein
therebi
mask
whole
bacteria
macrophag
detect
importantli
coiledcoil
structur
protein
strikingli
similar
myocardi
muscl
protein
antibodi
made
protein
therefor
inadvert
crossreact
myocardi
cell
result
carditi
peak
arf
late
childhood
may
reflect
time
need
go
sever
bout
gabh
pharyng
thu
produc
higher
antibodi
level
respons
infect
higher
antibodi
level
eventu
caus
sever
cardiac
damag
reaction
luckili
wane
adult
arf
distinctli
unusu
older
individu
protein
serotyp
rheumatogen
specif
serotyp
eg
red
lake
strain
caus
agn
complic
due
antigenantibodi
deposit
kidney
first
year
life
pharyng
rare
one
seri
case
pharyng
occur
children
younger
year
age
relat
gabh
infrequ
gabh
almost
total
absenc
arf
infant
younger
year
old
use
diagnost
test
gabh
age
group
limit
seromucoid
rhiniti
streptococcosi
affect
age
group
nonsuppur
sequela
occur
howev
endem
yearround
gabh
pharyng
peak
occurr
late
winter
earli
spring
incub
period
day
patient
develop
sudden
onset
sore
throat
pain
swallow
chill
fever
c
headach
nausea
vomit
abdomin
pain
common
physic
examin
mark
erythema
throat
tonsil
accompani
patchi
discret
tonsillar
exud
enlarg
tender
anterior
cervic
lymph
node
uvular
edema
sometim
typic
scarlet
fever
rash
palat
petechia
fig
scarlet
fever
affect
trunk
cheek
palm
sole
evid
antecubit
space
pastia
sign
axilla
often
accompani
circumor
pallor
minut
vesicl
abdomen
miliari
sudamina
resolv
skin
desquam
usual
cours
sign
arf
urticaria
may
occur
respons
gabh
infect
initi
white
strawberri
tongu
denud
becom
classic
red
strawberri
tongu
sever
rhiniti
cough
conjunct
laryng
croup
diarrhea
suggest
caus
gabh
white
blood
cell
count
often
high
may
show
eosinophilia
untreat
gabh
pharyng
shortliv
sore
throat
resolv
day
fever
day
scarlet
fever
day
antibiot
speed
recoveri
day
percentag
person
acut
gabh
pharyng
sever
ill
versu
mildli
affect
unknown
mani
school
children
carri
streptococci
throat
winter
yet
bout
signific
gabh
pharyng
occur
averag
everi
year
mani
infect
therefor
must
rel
asymptomat
nearli
asymptomat
patient
unfortun
still
contract
arf
one
patient
arf
symptom
upper
respiratori
tract
infect
sore
throat
taken
physician
throat
cultur
six
throat
cultur
posit
complianc
rate
prescrib
antibiot
unknown
throat
cultur
remain
effect
method
diagnosi
gabh
cultur
throat
gabh
steril
cotton
swab
rub
tonsil
tonsillar
fossa
posterior
pharynx
prefer
second
practic
necessari
swab
place
dri
steril
paper
wrapper
left
room
temperatur
hour
prefer
less
hour
sheep
blood
agar
plate
inocul
swab
fig
stab
made
agar
bacitracin
disc
u
bacitracin
disc
appli
plate
read
hour
posit
cultur
show
beta
hemolysi
ring
inhibit
disc
pinheads
plate
gabh
requir
roll
throat
swab
across
area
sheep
blood
agar
plate
wire
loop
heat
red
briefli
cool
two
pass
made
area
spread
area
process
repeat
area
attempt
isol
singl
coloni
gabh
loop
heat
stab
made
agar
first
area
two
area
loop
flame
red
use
final
disc
appli
lightli
tap
area
plate
label
incub
upsid
white
coloni
ring
hemolysi
least
twice
larg
slid
across
agar
without
disrupt
recent
confirm
tradit
method
accur
carbon
dioxideenhanc
incub
select
blood
agar
medium
special
transport
medium
toddhewitt
broth
anaerob
incub
atmospher
singl
sheep
blood
agar
plate
sensit
compar
system
throat
cultur
plate
cost
cent
time
set
read
clinic
laboratori
improv
act
monitor
increas
cost
rapid
streptococc
antigen
detect
kit
also
great
util
make
diagnosi
manufactur
produc
k
although
claim
specif
true
neg
clinic
trial
suggest
accur
manufactur
claim
sensit
true
posit
substanti
found
clinic
trial
howev
case
suspect
gabh
therefor
neg
rapid
streptococc
antigen
test
confirm
throat
rapid
streptococc
kit
cost
optic
immunoassay
technolog
may
offer
result
superior
standard
rapid
streptococc
figur
present
scheme
use
test
appropri
decis
sever
pharyng
especi
whether
major
complaint
requir
initi
plan
avoid
excess
test
major
rapid
streptococc
test
neg
mild
diseas
throat
cultur
necessari
addit
rapid
streptococc
test
might
benefici
sever
diseas
mani
physician
treat
basi
clinic
find
set
wherea
withhold
treatment
moder
ill
test
neg
gabh
still
suspect
carrier
state
suspect
proof
gabh
invas
desir
blood
test
antibodi
streptococc
exotoxin
employ
antistreptolysin
titer
po
itiv
todd
u
streptozym
test
antidnas
b
antihyaluronidas
antinadas
antistreptokinas
may
posit
patient
gabh
form
pharyng
receiv
symptomat
treatment
gargl
warm
saltwat
drink
warm
liquid
rest
import
one
ibuprofen
prove
superior
acetaminophen
symptomat
relief
children
simultan
use
may
better
arguabl
whether
definit
therapi
form
antibiot
need
provid
immedi
reliev
symptom
gabh
pharyng
relief
obtain
immedi
antibiot
treatment
gener
small
usual
fever
improv
sore
throat
delay
least
symptomat
support
seem
provid
excel
relief
without
immedi
penicillin
although
expert
fear
earli
treatment
may
predispos
higher
rate
recurr
gabh
pharyng
one
major
suggest
problem
unlik
howev
immedi
treatment
might
allow
earlier
return
work
school
supposit
remain
unproven
definit
treatment
prescript
penicillin
v
mg
oral
three
four
time
day
day
total
complianc
assur
twice
day
penicillin
cheap
effect
prevent
arf
rel
nongabh
uniformli
sensit
penicillin
recoveri
day
treatment
much
lower
day
patient
must
use
im
possibl
amoxicillin
may
substitut
tast
better
penicillin
one
risk
diarrhea
rash
increas
resist
bacteria
amoxicillin
intramuscular
benzathin
penicillin
g
u
weigh
less
lb
kg
million
u
heavier
individu
also
definit
treatment
take
oral
penicillin
individu
allerg
penicillin
erythromycin
mgkg
two
four
divid
dose
per
day
g
maximum
day
erythromycinresist
streptococci
report
major
problem
unit
state
clarithromycin
azithromyin
also
effect
costli
use
firstlin
therapi
two
agent
howev
elimin
almost
bacteria
caus
pharyng
well
clarithromycin
come
mg
mg
per
ml
tablet
given
mgkg
twice
day
mgdose
maximum
day
azithromycin
avail
mg
mg
per
ml
capsul
given
mgkg
day
day
firstgener
cephalosporin
cephalexin
mgkg
mg
three
four
time
day
day
effect
initi
recurr
diseas
clindamycin
use
individu
recurr
pharyng
fail
penicillin
treatment
allerg
cephalosporin
higher
gener
cephalosporin
effect
expens
altern
common
problem
tetracyclin
sulfonamid
wr
k
penicillin
treatment
throat
cultur
remain
posit
gabh
altern
antibiot
elimin
gabh
throat
case
includ
eftibuten
cefpodoxim
proetil
cefprozil
axetil
loracarbef
ephalexin
cefalor
like
other
howev
agent
offer
advantag
penicillin
prevent
arf
speed
recoveri
initi
elimin
gabh
throat
treatment
penicillin
appropri
antibiot
blunt
product
antidnas
b
tonsillectomi
may
help
recurr
gabh
pharyng
reserv
children
least
seven
document
infect
year
five
year
three
year
prerequisit
pharyng
rate
decreas
tonsillectomi
end
antibiot
therapi
individu
remain
posit
gabh
patient
carri
gabh
sever
week
longer
danger
individu
serum
antibodi
reaction
occur
number
coloni
streptococci
found
throat
cultur
usual
lower
carrier
acut
one
postul
mani
initi
fals
neg
throat
cultur
repres
carrier
rather
truli
infect
individu
contagi
other
luckili
relat
invers
length
time
carri
gabhsio
recultur
avoid
problem
recommend
five
percent
repeat
throat
cultur
posit
gabh
probabl
noncompli
antibiot
regimen
arf
symptomat
pharyng
rare
situat
howev
suggest
account
failur
penicillin
bacteri
toler
synergist
bacteri
protect
gabh
proven
author
present
advis
cultur
contact
contact
symptomat
clinician
caution
respons
person
question
children
presenc
symptom
possibl
arf
occurr
rel
asymptmat
reservoir
gabh
like
human
outsid
famili
although
pet
implic
potenti
sourc
recurr
diseas
recent
studi
found
gabh
carriag
random
screen
survey
household
child
acut
pharyng
children
pet
found
harbor
sibl
acut
gabh
pharyng
may
gabh
often
differ
serotyp
recurr
rate
may
higher
famili
gabhsinfest
sibl
carrier
data
challeng
tradit
idea
children
within
singl
household
constantli
pass
gabh
one
anoth
increas
incid
arf
sinc
requir
continu
attent
gabh
pharyng
revis
jone
criteria
diagnosi
arf
list
tabl
recent
experi
unfortun
shown
mani
person
develop
arf
never
ill
pharyng
therefor
never
seen
physician
experi
children
hospit
pittsburgh
patient
arf
found
outpati
treatment
frequent
satisfactori
patient
carditi
arthriti
chorea
carditi
arthriti
carditi
chorea
chorea
arthriti
chorea
carditi
arthriti
overal
children
carditi
children
usual
recov
without
perman
valvular
damag
contradistinct
adult
arf
arthriti
wherea
carditi
uncommon
appropri
treatment
gabh
pharyng
abort
initi
attack
arf
usual
occur
week
pharyng
delay
onset
carditi
chorea
common
individu
suffer
one
attack
arf
prophylact
treatment
prevent
bout
arf
signific
cardiac
damag
four
regimen
approv
pro
phyla
xi
b
fever
note
abdomin
pain
epistaxi
tachycardia
also
common
laboratori
prolong
pr
interv
b
elev
acut
phasereact
erythrocyt
sediment
rate
creactiv
protein
ii
two
major
criteria
one
major
two
minor
criteria
plu
patient
previous
afflict
rheumat
fever
one
major
minorcriterion
suggest
recurr
rheumat
fever
given
aforement
guidelin
diagnosi
rheumat
feverjon
criteria
updat
jama
copyright
american
medic
associ
permiss
penicillin
v
mg
oral
twice
day
benzathin
penicillin
g
million
u
intramuscularli
everi
week
sulfisoxazol
g
oral
day
person
weigh
erythromycin
mg
oral
twice
day
kg
lb
mg
weigh
less
daili
antibiot
includ
use
acn
also
like
effect
patient
given
sulfisoxazol
get
blood
count
week
therapi
begun
look
leukopenia
debat
durat
arf
prophylaxi
mitig
introspect
risk
arf
highest
age
arf
victim
take
prophylaxi
least
age
although
favor
age
year
cutoff
addit
minimum
year
prophylaxi
seem
wise
although
favor
lifelong
treatment
patient
sever
carditi
initi
bout
arf
exist
sever
arf
carditi
live
gabhsepidem
condit
wish
receiv
prophylaxi
offer
longer
cours
guidelin
prevent
subacut
bacteri
endocard
avail
multipl
sourc
includ
red
guidelin
indic
prevent
cardiac
infect
pharyng
agn
follow
gabh
pharyng
afflict
mostli
earli
schoolag
children
winter
spring
famili
occurr
common
attack
rate
infect
nephritogen
strain
strain
unusu
spread
epidem
wave
overal
occurr
agn
latenc
follow
onset
pharyng
follow
edema
hypertens
rusti
urin
urinalysi
reveal
proteinuria
hematuria
one
mechan
propos
account
renal
damag
antigenantibodi
deposit
glomeruli
penicillin
treatment
pharyng
unfortun
seem
prevent
agn
abort
dissemin
nephritogen
strain
treatment
otherwis
support
aim
control
blood
pressur
edema
renal
scar
lifelong
proteinuria
hematuria
infrequ
renal
failur
occur
nongroup
streptococci
produc
pharyng
indistinguish
gabh
colleg
student
adolesc
suffer
group
c
wherea
communitywid
foodborn
cold
hardboil
egg
pharyng
connect
group
g
organ
organ
link
nonsuppur
sequela
arf
produc
major
antibodi
respons
follow
gabh
infect
treatment
therefor
aim
sole
symptomat
relief
group
c
pharyng
often
less
sever
gabh
penicillin
erythromycin
provid
effect
therapi
ideal
length
treatment
unclear
group
c
g
caus
arf
patient
asymptomat
reason
continu
therapi
day
could
prevent
carriag
henc
potenti
hazard
other
prevent
recurr
whether
goal
achiev
fewer
day
treatment
investig
fulli
anaerob
infect
foul
breath
odor
accompani
membran
purul
exud
pharynx
tonsil
malnutrit
leukopenia
immunodefici
therapeut
neck
irradi
predispos
diseas
anaerob
includ
peptostreptococcu
fusobacterium
bacteroid
sensit
penicillin
complic
peritonsillar
abscess
quinsi
postangin
septicemia
lemierr
diseas
jugular
vein
thrmbophleb
pose
fear
consequ
immunocompromis
patient
anaerob
frequent
isol
peritonsillar
abscess
follow
throat
infect
clindamycin
penicillin
cephalosporin
penicillin
fortun
gener
effect
abscess
drain
arcanobacterium
haemolyticu
gramposit
earli
cultur
gramvari
later
cultur
rod
probabl
caus
acut
pharyng
indistinguish
gabh
pharyng
afflict
adolesc
young
adult
especi
soldier
uniformli
develop
sore
throat
pharyng
erythema
develop
exud
lymphadenopathi
primarili
anterior
cervic
submandibular
fever
c
f
pruritu
variabl
percentag
nonproduct
cough
tipoff
gabh
involv
palat
petechia
strawberri
tongu
found
scarlatiniform
rash
follow
pharyng
day
begin
extensor
surfac
spread
chest
back
half
patient
rash
pruritu
develop
urticaria
desquam
rare
manifest
includ
sepsi
skin
infect
deep
local
infect
diagnosi
depend
find
typic
pharyng
often
rash
adolesc
young
adult
neg
test
gabh
set
kaemolyticu
may
equal
incid
gabh
ie
pharyng
case
cultur
blood
agar
show
beta
hemolysi
incub
ideal
treatment
defin
erythromycin
mg
oral
four
time
day
day
probabl
adequ
penicillin
probabl
ineffect
wherea
role
cephalosporin
quinolon
unclear
clarithromycin
azithromycin
like
efficaci
borrelia
burgdorferi
agent
lyme
diseas
produc
isol
pharyng
person
lymerel
symptom
b
recurrenti
caus
relaps
fever
infrequ
produc
mild
sore
throat
chlamydia
pneumonia
produc
fever
cough
mitig
gabh
sore
pharyng
occur
without
pneumonia
concomitantli
preced
week
prolong
pharyng
report
oral
erythromycin
may
clear
case
best
children
wherea
tetracyclin
use
adult
terribl
form
pharyng
diphtheria
still
strike
underdevelop
countri
underimmun
popul
recent
outbreak
russia
led
diphtheria
citizen
unit
incub
period
day
present
slowli
worsen
mild
sore
throat
lowgrad
fever
tonsillar
pharyng
exud
thick
membran
gray
appear
remov
membran
reveal
bleed
surfac
victim
develop
weak
prostrat
cervic
adenopathi
swell
neck
typic
bull
anterior
nare
often
white
membran
serosanguin
discharg
common
ill
travel
larynx
respiratori
stridor
develop
nonintub
patient
becom
exhaust
die
cardiac
neurolog
toxic
common
fortun
diphtheria
fulli
prevent
immun
coupl
support
care
penicillin
erythromycin
effect
treatment
diphtheria
antitoxin
use
avail
center
diseas
control
prevent
co
ynebacterium
ulceran
caus
pharyng
person
drink
raw
milk
debat
whether
c
pyogen
caus
human
diseas
pharyng
predomin
symptom
infect
mycoplasma
p
n
em
n
e
insidi
onset
headach
fever
follow
sore
throat
often
cough
contrari
gabh
coryza
throat
red
slight
exud
anterior
cervic
lymph
node
tender
promin
pneumonia
tracheobronch
also
may
present
tetracyclin
erythromycin
provid
effect
treatment
incid
pneurnonia
pharyng
debat
estim
rang
case
may
afflict
young
adult
commonli
orogenit
sexual
activ
neisseria
gonorrkoea
infect
pharynx
women
gonorrheainfect
partner
homosexu
men
higher
rate
infect
infect
asymptomat
mild
pharyng
cervic
lymphadenopathi
well
describ
adolesc
adult
oral
oropharyng
ulcer
rag
border
may
gonorrh
diseas
cours
syphili
also
must
suspect
pharyng
infect
best
treat
ceftriaxon
mg
intramedullarli
plu
doxycyclin
mg
oral
twice
day
day
n
meningitid
pharyng
report
preced
sepsi
ill
must
rare
francisella
tularensi
present
oropharyng
infect
acut
membran
exud
pharyng
cervic
lymphaden
rabbitassoci
tickborn
transmiss
infect
cervic
lymph
node
case
adult
yersinia
enterocolitica
produc
pharyng
without
gastroenter
commonli
found
children
mesenter
aden
mimic
append
fever
promin
cervic
adenopathi
usual
exud
describ
case
fulmin
cours
lead
death
make
earli
recognit
treatment
aminoglycosid
thirdgener
cephalosporin
trimethoprimsulfamethoxazol
effect
penicillin
kawasaki
diseas
specif
diagnost
clue
list
tabl
infant
toddler
younger
age
often
affect
older
children
reportedli
affect
within
day
onset
fever
find
present
tabl
develop
conjunct
erythemat
lip
mouth
singlerod
anterior
cervic
adenopathi
prolong
high
fever
despit
antibiot
treatment
present
distinct
clinic
pictur
associ
vascul
coronari
arteri
lead
vascular
aneurysm
ruptur
thrombosi
death
complic
untreat
patient
includ
anterior
uveiti
steril
pyuria
arthriti
asept
mening
carditi
congest
failur
pericardi
effus
arrhythmia
gallbladd
hydrop
sometim
jaundic
desquam
skin
usual
day
fig
overal
diseas
last
month
untreat
treatment
immedi
effect
consist
highdos
intraven
immunoglobulin
within
day
onset
given
g
per
kg
plu
aspirin
mgkgd
four
divid
dose
fever
control
dose
reduc
mg
per
kg
one
daili
dose
month
echocardiogram
week
week
detect
format
coronari
arteri
aneurysm
allerg
diathes
especi
chronic
rhiniti
frequent
produc
pharyng
manifest
red
dryness
mucu
pharynx
trauma
cours
usual
sudden
onset
delay
irrit
especi
alcohol
user
com
tabl
criteria
kawasaki
diseas
number
plu
least
four
criteria
must
present
fever
gener
f
least
durat
despit
antibiot
use
bilater
nonpurul
bulbar
conjunct
erythemat
mouth
pharynx
strawberri
tongu
crack
red
lip
gener
polymorph
erythemat
rash
usual
solitari
anterior
cervic
lymph
node
enlarg
cm
diamet
edema
erythema
hand
feet
periungu
desquam
peel
palm
later
diseas
process
must
exclud
erythrocyt
sediment
rate
often
elev
markedlv
mon
swallow
foreign
bodi
includ
dentur
may
caus
drool
odynophagia
burn
hot
food
acid
alkali
often
sever
may
scar
ingest
less
toxic
oral
irrit
substanc
question
occup
histori
may
help
exampl
ammonia
preserv
food
chees
cracker
irrit
throat
food
ingest
hot
product
line
excess
cigarett
smoke
especi
bothersom
produc
recurr
sore
throat
children
household
smoker
smoke
inhal
fire
irrit
chew
tobacco
caus
pharyng
dryness
throat
often
caus
complaint
earlymorn
sore
throat
person
obstruct
sleep
apnea
nasal
blockad
palat
dysfunct
breath
mouth
particularli
prone
problem
afflict
children
frequent
snore
night
dryness
cold
exacerb
issu
stress
home
work
induc
psychosomat
sore
throat
often
prolong
difficult
problem
excess
shout
cheer
sing
produc
sore
throat
hoars
chronic
nasal
blockag
present
adenoid
hypertrophi
nasal
polyp
even
nasopharyng
cancer
consid
latter
relat
ebv
found
mainli
adult
found
adolesc
also
may
suffer
lymphoma
hodgkin
diseas
triad
pain
swallow
otalgia
particularli
serou
otiti
media
adult
hoars
suggest
nasopharyng
carcinoma
patient
epiglott
caus
h
influenza
type
b
prevent
appropri
use
conjug
hib
vaccin
supraglott
caus
gabh
croup
laryngotracheobronch
caus
viru
usual
parainfluenza
laryng
usual
viral
stressinduc
also
may
present
complaint
sore
throat
although
throat
appear
normal
trench
mouth
ulcer
gingiv
may
involv
tonsil
ulcer
bleed
yellowgray
membran
particularli
common
human
immunodefici
syndrom
neutropenia
subacut
thyroid
produc
refer
pain
throat
infrequ
fever
pain
swallow
n
drool
without
complaint
sore
throat
signal
presenc
uvul
gabh
age
year
h
influenza
type
b
age
year
usual
culprit
concomit
tonsil
epiglott
respect
occur
uvula
red
swollen
cultur
blood
uvula
usual
reveal
offend
organ
treatment
broad
spectrum
plactamaseresist
antibiot
intraven
cultur
allow
narrow
choic
